English

Eligibility Type 2 Diabetes NCT00508287

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of type 2 diabetes for ≥ 3 months treated with metformin, thiazolidinedione, or sulfonylurea (either monotherapy or combination) or diet alone (drug naïve)
Description

Diabetes Mellitus, Non-Insulin-Dependent | Metformin | Thiazolidinediones | Sulfonylurea | Combined Modality Therapy | Diet therapy Without Pharmaceutical Preparations

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0025598
UMLS CUI [3]
C1257987
UMLS CUI [4]
C0038766
UMLS CUI [5]
C0009429
UMLS CUI [6,1]
C0012159
UMLS CUI [6,2]
C0332288
UMLS CUI [6,3]
C0013227
fasting plasma glucose: 126 - 240 mg/dl
Description

Plasma fasting glucose measurement

Data type

boolean

Alias
UMLS CUI [1]
C0583513
hemoglobin a1c: 6 - 10%
Description

Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0019018
estimated crcl ≥ 60 ml/min
Description

Creatinine clearance measurement Estimated

Data type

boolean

Alias
UMLS CUI [1,1]
C0373595
UMLS CUI [1,2]
C0750572
alt ≤ 1.5 x uln and total bilirubin ≤ 2 x uln
Description

Alanine aminotransferase measurement | Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C1278039
stable and well controlled hypertension and/or dyslipidemia
Description

Hypertensive disease Stable | Hypertension controlled well | Dyslipidemia

Data type

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0745117
UMLS CUI [2,2]
C0205170
UMLS CUI [3]
C0242339
concomitant medications used for hypertension and/or dyslipidemia, thyroid hormone replacement therapy and low dose aspirin will be allowed if stable for at least 6 weeks
Description

Pharmaceutical Preparations Hypertensive disease | Pharmaceutical Preparations Dyslipidemia | Thyroid hormone replacement therapy | Aspirin Low Dose Stable

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0020538
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0242339
UMLS CUI [3]
C2242640
UMLS CUI [4,1]
C2608320
UMLS CUI [4,2]
C0205360
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
women of childbearing potential
Description

Childbearing Potential

Data type

boolean

Alias
UMLS CUI [1]
C3831118
symptomatic diabetes with polyuria and/or polydipsia
Description

Diabetes Mellitus Symptomatic | Polyuria | Polydipsia

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0231220
UMLS CUI [2]
C0032617
UMLS CUI [3]
C0085602
history of diabetic ketoacidosis or hyperosmolar nonketotic syndrome
Description

Diabetic Ketoacidosis | Hyperglycaemic hyperosmolar nonketotic syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0011880
UMLS CUI [2]
C1504377
history of renal disease including diabetic nephropathy
Description

Kidney Disease | Diabetic Nephropathy

Data type

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C0011881
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes NCT00508287

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Metformin | Thiazolidinediones | Sulfonylurea | Combined Modality Therapy | Diet therapy Without Pharmaceutical Preparations
Item
diagnosis of type 2 diabetes for ≥ 3 months treated with metformin, thiazolidinedione, or sulfonylurea (either monotherapy or combination) or diet alone (drug naïve)
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C1257987 (UMLS CUI [3])
C0038766 (UMLS CUI [4])
C0009429 (UMLS CUI [5])
C0012159 (UMLS CUI [6,1])
C0332288 (UMLS CUI [6,2])
C0013227 (UMLS CUI [6,3])
Plasma fasting glucose measurement
Item
fasting plasma glucose: 126 - 240 mg/dl
boolean
C0583513 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hemoglobin a1c: 6 - 10%
boolean
C0019018 (UMLS CUI [1])
Creatinine clearance measurement Estimated
Item
estimated crcl ≥ 60 ml/min
boolean
C0373595 (UMLS CUI [1,1])
C0750572 (UMLS CUI [1,2])
Alanine aminotransferase measurement | Serum total bilirubin measurement
Item
alt ≤ 1.5 x uln and total bilirubin ≤ 2 x uln
boolean
C0201836 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Hypertensive disease Stable | Hypertension controlled well | Dyslipidemia
Item
stable and well controlled hypertension and/or dyslipidemia
boolean
C0020538 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0745117 (UMLS CUI [2,1])
C0205170 (UMLS CUI [2,2])
C0242339 (UMLS CUI [3])
Pharmaceutical Preparations Hypertensive disease | Pharmaceutical Preparations Dyslipidemia | Thyroid hormone replacement therapy | Aspirin Low Dose Stable
Item
concomitant medications used for hypertension and/or dyslipidemia, thyroid hormone replacement therapy and low dose aspirin will be allowed if stable for at least 6 weeks
boolean
C0013227 (UMLS CUI [1,1])
C0020538 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0242339 (UMLS CUI [2,2])
C2242640 (UMLS CUI [3])
C2608320 (UMLS CUI [4,1])
C0205360 (UMLS CUI [4,2])
Item Group
C0680251 (UMLS CUI)
Childbearing Potential
Item
women of childbearing potential
boolean
C3831118 (UMLS CUI [1])
Diabetes Mellitus Symptomatic | Polyuria | Polydipsia
Item
symptomatic diabetes with polyuria and/or polydipsia
boolean
C0011849 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0032617 (UMLS CUI [2])
C0085602 (UMLS CUI [3])
Diabetic Ketoacidosis | Hyperglycaemic hyperosmolar nonketotic syndrome
Item
history of diabetic ketoacidosis or hyperosmolar nonketotic syndrome
boolean
C0011880 (UMLS CUI [1])
C1504377 (UMLS CUI [2])
Kidney Disease | Diabetic Nephropathy
Item
history of renal disease including diabetic nephropathy
boolean
C0022658 (UMLS CUI [1])
C0011881 (UMLS CUI [2])
Back to the top of the page